ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Joellen Schildkraut

Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada

Biography

Joellen Schildkraut is currently working as a Professor. The author's research interests include Clinical Pathology, Histopathology, Hemato Pathology, Surgical Pathology, Diagnosis. The author is serving as an editorial member and reviewer of several international reputed journals. The author has successfully completed his Administrative responsibilities. The author has authorized many research articles/books related to Clinical Pathology, Experimental Pathology

Publications

Uncertainty in the Utility of Mismatch Repair Protein Expression measured by Immunohistochemistry in a Multicenter Population-based Study of Epithelial Ovarian Cancer

immunohistochemistry (IHC) for MMR protein expression. Although the utility of IHC has been demonstrated in colorectal cancer, its utility in ovarian cancer remains incompletely defined. We sought to evaluate the loss of protein expression of the MMR proteins (MLH1, MSH2 and MSH6) in three population-based samples of epithelial ovarian cancers. ... Read More»

Domenico Coppola, Santo V. Nicosia, Andrea Doty, Thomas A Sellers, Ji-Hyun Lee, Jimmy Fulp, Zachary Thompson, Sanja Galeb, John McLaughlin, Steven A Narod, Joellen Schildkraut and Tuya Pal

Research Article: J Clin Exp Pathol 2012, 2: 115

DOI: 10.4172/2161-0681.1000115

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top